We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Almac Sciences, a member of the Almac Group, has completed a roughly $7 million investment in a new two-storey center for biocatalysis, flow chemistry technologies and peptide research and development.